Macrolide resistance in Streptococcus pneumoniae in Hong Kong

Antimicrob Agents Chemother. 2001 May;45(5):1578-80. doi: 10.1128/AAC.45.5.1578-1580.2001.

Abstract

Erythromycin resistance rates among penicillin-susceptible Streptococcus pneumoniae were 38 and 92% among penicillin-intermediate and -resistant S. pneumoniae isolates from Hong Kong, respectively, and 27% (43 of 158) of the isolates showed the MLS(B) phenotype, and the majority carried the ermB gene; 73% (115 of 158) displayed the M phenotype, and all possessed the mef gene. The MLS(B) phenotype was predominant in penicillin-susceptible, macrolide-resistant isolates and in penicillin-nonsusceptible isolates of serotype 6B, whilst the M phenotype was predominant in penicillin-intermediate or -resistant isolates belonging to serotype 23F or 19F. Extensive spread of clones of drug-resistant pneumococci has led to the widespread presence of macrolide resistance in S. pneumoniae in Hong Kong.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Drug Resistance, Microbial
  • Erythromycin / pharmacology*
  • Hong Kong
  • Humans
  • Microbial Sensitivity Tests
  • Penicillins / pharmacology
  • Phenotype
  • Serotyping
  • Streptococcus pneumoniae / drug effects*
  • Streptococcus pneumoniae / immunology

Substances

  • Anti-Bacterial Agents
  • Penicillins
  • Erythromycin